blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0490590

EP0490590 - New benzodiazepine analogs [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.01.1996
Database last updated on 06.07.2024
Most recent event   Tooltip26.01.1996Application deemed to be withdrawnpublished on 13.03.1996 [1996/11]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1992/25]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / Bock, Mark G.
1603 Leon Drive
Hatfield, PA 19440 / US
02 / Evans, Ben E.
501 Perkiomen Avenue
Lansdale, PA 19446 / US
03 / Freidinger, Roger M.
744 Newport Lane
Lansdale, PA 19446 / US
[1992/25]
Representative(s)Thompson, John, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1992/25]Thompson, John Dr., et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date91311364.306.12.1991
[1992/25]
Priority number, dateUS1990062347307.12.1990         Original published format: US 623473
US1991071848820.06.1991         Original published format: US 718488
[1992/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0490590
Date:17.06.1992
Language:EN
[1992/25]
Search report(s)(Supplementary) European search report - dispatched on:EP30.03.1992
ClassificationIPC:C07D243/18, C07D243/24, C07D243/26, C07D401/06, C07D403/06, C07D403/12, A61K31/55
[1992/25]
CPC:
C07D401/12 (EP); A61P25/04 (EP); A61P25/20 (EP);
A61P25/30 (EP); A61P27/02 (EP); A61P43/00 (EP);
C07D243/24 (EP); C07D403/12 (EP); C07D471/04 (EP) (-)
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI,   NL [1992/25]
TitleGerman:Neue Analoga des Benzodiazepin[1992/25]
English:New benzodiazepine analogs[1992/25]
French:Nouveaux analogues de benezodiazépine[1992/25]
File destroyed:20.04.2002
Examination procedure06.11.1992Examination requested  [1993/01]
06.03.1995Despatch of a communication from the examining division (Time limit: M06)
19.09.1995Application deemed to be withdrawn, date of legal effect  [1996/11]
19.10.1995Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1996/11]
Fees paidRenewal fee
08.10.1993Renewal fee patent year 03
02.01.1995Renewal fee patent year 04
02.01.1996Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AP]EP0434364  (MERCK & CO INC [US]);
 [AD]EP0167919  (MERCK & CO INC [US]);
 [AD]EP0167920  (MERCK & CO INC [US]);
 [AP]EP0434360  (MERCK & CO INC [US]);
 [AD]US4820834  (EVANS BEN E [US], et al);
 [AD]EP0360079  (FUJISAWA PHARMACEUTICAL CO [JP]);
 [AD]EP0340064  (JOUVEINAL SA [FR])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.